AC
DCPH

Aaron Cowen’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Aaron Cowen’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-862,126
Closed -$29.3M – 117
2021
Q3 		$29.3M Buy
862,126
+209,491
+32% +$6.69M 0.49% 43
2021
Q2 		$23.9M Buy
652,635
+315,827
+94% +$12.2M 0.36% 57
2021
Q1 		$15.1M Buy
+336,808
New +$15.7M 0.22% 64

Other funds holding DCPH

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Aaron Cowen's DCPH Position: Q4 2021 in Review

Aaron Cowen sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 862,126 shares — an estimated $29.3M sold.

Aaron Cowen first reported a position in DCPH in Q1 2021 and held it in 3 quarters. The position peaked at $29.3M in Q3 2021. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

  • Aaron Cowen reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Aaron Cowen sold 862,126 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $29.3M.
  • Aaron Cowen first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Aaron Cowen's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $29.3M in Q3 2021.
  • 140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Suvretta Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.